300 related articles for article (PubMed ID: 23339722)
1. A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice.
Zhou H; Janghra N; Mitrpant C; Dickinson RL; Anthony K; Price L; Eperon IC; Wilton SD; Morgan J; Muntoni F
Hum Gene Ther; 2013 Mar; 24(3):331-42. PubMed ID: 23339722
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy Δ7 mouse model phenotype.
Nizzardo M; Simone C; Salani S; Ruepp MD; Rizzo F; Ruggieri M; Zanetta C; Brajkovic S; Moulton HM; Müehlemann O; Bresolin N; Comi GP; Corti S
Clin Ther; 2014 Mar; 36(3):340-56.e5. PubMed ID: 24636820
[TBL] [Abstract][Full Text] [Related]
3. Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response.
Zhou H; Meng J; Marrosu E; Janghra N; Morgan J; Muntoni F
Hum Mol Genet; 2015 Nov; 24(22):6265-77. PubMed ID: 26264577
[TBL] [Abstract][Full Text] [Related]
4. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse.
Porensky PN; Mitrpant C; McGovern VL; Bevan AK; Foust KD; Kaspar BK; Wilton SD; Burghes AH
Hum Mol Genet; 2012 Apr; 21(7):1625-38. PubMed ID: 22186025
[TBL] [Abstract][Full Text] [Related]
5. Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models.
Osman EY; Miller MR; Robbins KL; Lombardi AM; Atkinson AK; Brehm AJ; Lorson CL
Hum Mol Genet; 2014 Sep; 23(18):4832-45. PubMed ID: 24781211
[TBL] [Abstract][Full Text] [Related]
6. Morpholino-Mediated Exon Inclusion for SMA.
Zhou H; Muntoni F
Methods Mol Biol; 2018; 1828():467-477. PubMed ID: 30171560
[TBL] [Abstract][Full Text] [Related]
7. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.
Singh NK; Singh NN; Androphy EJ; Singh RN
Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646
[TBL] [Abstract][Full Text] [Related]
8. Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy.
Baughan TD; Dickson A; Osman EY; Lorson CL
Hum Mol Genet; 2009 May; 18(9):1600-11. PubMed ID: 19228773
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy.
Osman EY; Yen PF; Lorson CL
Mol Ther; 2012 Jan; 20(1):119-26. PubMed ID: 22031236
[TBL] [Abstract][Full Text] [Related]
10. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy.
Mitrpant C; Porensky P; Zhou H; Price L; Muntoni F; Fletcher S; Wilton SD; Burghes AH
PLoS One; 2013; 8(4):e62114. PubMed ID: 23630626
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.
Son HW; Yokota T
Methods Mol Biol; 2018; 1828():57-68. PubMed ID: 30171534
[TBL] [Abstract][Full Text] [Related]
12. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.
Hua Y; Sahashi K; Hung G; Rigo F; Passini MA; Bennett CF; Krainer AR
Genes Dev; 2010 Aug; 24(15):1634-44. PubMed ID: 20624852
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.
Williams JH; Schray RC; Patterson CA; Ayitey SO; Tallent MK; Lutz GJ
J Neurosci; 2009 Jun; 29(24):7633-8. PubMed ID: 19535574
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
[TBL] [Abstract][Full Text] [Related]
15. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
Zhou H; Meng J; Malerba A; Catapano F; Sintusek P; Jarmin S; Feng L; Lu-Nguyen N; Sun L; Mariot V; Dumonceaux J; Morgan JE; Gissen P; Dickson G; Muntoni F
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):768-782. PubMed ID: 32031328
[TBL] [Abstract][Full Text] [Related]
16. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
17. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.
Singh NN; Lee BM; Singh RN
Ann N Y Acad Sci; 2015 Apr; 1341():176-87. PubMed ID: 25727246
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy.
Osman EY; Washington CW; Kaifer KA; Mazzasette C; Patitucci TN; Florea KM; Simon ME; Ko CP; Ebert AD; Lorson CL
Mol Ther; 2016 Sep; 24(9):1592-601. PubMed ID: 27401142
[TBL] [Abstract][Full Text] [Related]
19. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes.
Singh RN; Singh NN
Adv Neurobiol; 2018; 20():31-61. PubMed ID: 29916015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]